Concepedia

Publication | Open Access

1421MO Final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma

DOIFull Paper Access

26

Citations

0

References

2020

Year

S-E. Al-Batran, Georg-Martin Haag, Thomas J. Ettrich, K Borchert, A. Kretzschmar, Christian Teschendorf, Gabriele Margareta Siegler, M Ebert, Eray Goekkurt, Manfred Welslau,
Annals of Oncology

No additional data available for this publication yet. Check back later!